Cargando…
Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently har...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291141/ https://www.ncbi.nlm.nih.gov/pubmed/34264542 http://dx.doi.org/10.1111/ner.13494 |
_version_ | 1784749075017498624 |
---|---|
author | Dudding, Thomas C. Lehur, Paul A. Sørensen, Michael Engelberg, Stefan Bertapelle, Maria Paola Chartier‐Kastler, Emmanuel Everaert, Karel Van Kerrebroeck, Philip Knowles, Charles H. Lundby, Lilli Matzel, Klaus E. Muñoz‐Duyos, Arantxa Rydningen, Mona B. de Wachter, Stefan |
author_facet | Dudding, Thomas C. Lehur, Paul A. Sørensen, Michael Engelberg, Stefan Bertapelle, Maria Paola Chartier‐Kastler, Emmanuel Everaert, Karel Van Kerrebroeck, Philip Knowles, Charles H. Lundby, Lilli Matzel, Klaus E. Muñoz‐Duyos, Arantxa Rydningen, Mona B. de Wachter, Stefan |
author_sort | Dudding, Thomas C. |
collection | PubMed |
description | OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently hardware failure is detected. This article aims to provide practical guidance to solve sub‐optimal outcomes (troubleshooting) occurring in the course of SNM therapy. MATERIALS AND METHODS: A systematic literature review was performed. Collective clinical experience from an expert multidisciplinary group was used to form opinion where evidence was lacking. RESULTS: Circumstances in which reprogramming is required are described. Actions to undertake include changes of electrode configuration, stimulation amplitude, pulse frequency, and pulse width. Guidance in case of loss of efficacy and adverse effects of stimulation, developed by a group of European experts, is presented. In addition, various hardware failure scenarios and their management are described. CONCLUSIONS: Reprogramming aims to further improve patient symptoms or ensure a comfortable delivery of the therapy. Initial changes of electrode configuration and adjustment of stimulation parameters can be performed at home to avoid unnecessary hospital visits. A logical and stepwise approach to reprogramming can improve the outcome of therapy and restore patient satisfaction. |
format | Online Article Text |
id | pubmed-9291141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92911412022-07-20 Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice Dudding, Thomas C. Lehur, Paul A. Sørensen, Michael Engelberg, Stefan Bertapelle, Maria Paola Chartier‐Kastler, Emmanuel Everaert, Karel Van Kerrebroeck, Philip Knowles, Charles H. Lundby, Lilli Matzel, Klaus E. Muñoz‐Duyos, Arantxa Rydningen, Mona B. de Wachter, Stefan Neuromodulation GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently hardware failure is detected. This article aims to provide practical guidance to solve sub‐optimal outcomes (troubleshooting) occurring in the course of SNM therapy. MATERIALS AND METHODS: A systematic literature review was performed. Collective clinical experience from an expert multidisciplinary group was used to form opinion where evidence was lacking. RESULTS: Circumstances in which reprogramming is required are described. Actions to undertake include changes of electrode configuration, stimulation amplitude, pulse frequency, and pulse width. Guidance in case of loss of efficacy and adverse effects of stimulation, developed by a group of European experts, is presented. In addition, various hardware failure scenarios and their management are described. CONCLUSIONS: Reprogramming aims to further improve patient symptoms or ensure a comfortable delivery of the therapy. Initial changes of electrode configuration and adjustment of stimulation parameters can be performed at home to avoid unnecessary hospital visits. A logical and stepwise approach to reprogramming can improve the outcome of therapy and restore patient satisfaction. John Wiley & Sons, Inc. 2021-07-15 2021-10 /pmc/articles/PMC9291141/ /pubmed/34264542 http://dx.doi.org/10.1111/ner.13494 Text en © 2021 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals LLC on behalf of International Neuromodulation Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS Dudding, Thomas C. Lehur, Paul A. Sørensen, Michael Engelberg, Stefan Bertapelle, Maria Paola Chartier‐Kastler, Emmanuel Everaert, Karel Van Kerrebroeck, Philip Knowles, Charles H. Lundby, Lilli Matzel, Klaus E. Muñoz‐Duyos, Arantxa Rydningen, Mona B. de Wachter, Stefan Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title | Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title_full | Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title_fullStr | Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title_full_unstemmed | Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title_short | Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice |
title_sort | reprogramming sacral neuromodulation for sub‐optimal outcomes: evidence and recommendations for clinical practice |
topic | GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291141/ https://www.ncbi.nlm.nih.gov/pubmed/34264542 http://dx.doi.org/10.1111/ner.13494 |
work_keys_str_mv | AT duddingthomasc reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT lehurpaula reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT sørensenmichael reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT engelbergstefan reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT bertapellemariapaola reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT chartierkastleremmanuel reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT everaertkarel reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT vankerrebroeckphilip reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT knowlescharlesh reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT lundbylilli reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT matzelklause reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT munozduyosarantxa reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT rydningenmonab reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice AT dewachterstefan reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice |